Summary:
Single arm pivotol trial to assess the efficacy of AKL-T01. AKL-T01 is a digital therapeutic device.
Qualified Participants Must:
• Adults 18 years and older
•
Diagnosed with ADHD combined or Inattentive type
•
Must be available for two visits in office
•
Stable with or without medication 4 weeks prior to study enrollment
Qualified Participants May Receive:
No insurance is needed
Compensation for time and travel(if volunteers qualify)
Transportation is provided